ES2177787T3 - Uso de hidroxietil-almidon para evitar la formacion de adhesiones post-operatorias y como dispositivo de barrera intra-cavidades. - Google Patents
Uso de hidroxietil-almidon para evitar la formacion de adhesiones post-operatorias y como dispositivo de barrera intra-cavidades.Info
- Publication number
- ES2177787T3 ES2177787T3 ES96916821T ES96916821T ES2177787T3 ES 2177787 T3 ES2177787 T3 ES 2177787T3 ES 96916821 T ES96916821 T ES 96916821T ES 96916821 T ES96916821 T ES 96916821T ES 2177787 T3 ES2177787 T3 ES 2177787T3
- Authority
- ES
- Spain
- Prior art keywords
- hes
- hydroxietil
- almidon
- adhesions
- intra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
SE DESCRIBE EL HIDROXIETILALMIDON (HES) Y EL USO DEL MISMO EN PROCEDIMIENTOS PARA REDUCIR O PREVENIR LA FORMACION DE UNA ADHESION ENTRE SUPERFICIES TISULARES, POR EJEMPLO SUPERFICIES DE ORGANOS, EN CAVIDADES CORPORALES DESPUES DE PROCEDIMIENTOS QUIRURGICOS Y PARA LA ADMINISTRACION DE FARMACOS. EL HES PUEDE UTILIZARSE COMO UNA BARRERA MECANICA ABSORBIBLE POR SI SOLO O JUNTO CON UNO O MAS COMPUESTOS ANTI RA LA APLICACION A AREAS DAÑADAS DE TEJIDOS, POR EJEMPLO ORGANOS, SITUADOS EN CAVIDADES CORPORALES TALES COMO LAS CAVIDADES PERITONEAL, PELVICA, PLEURAL, EL SISTEMA NERVIOSO CENTRAL Y EL ESPACIO INTERLIGAMENTOSO. EL HES TAMBIEN PUEDE UTILIZARSE COMO UN DISPOSITIVO VEHICULO INTRACAVIDAD PARA LA ADMINISTRACION DE AGENTES FARMACEUTICAMENTE ACTIVOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/482,235 US5807833A (en) | 1995-06-07 | 1995-06-07 | Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2177787T3 true ES2177787T3 (es) | 2002-12-16 |
Family
ID=23915271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96916821T Expired - Lifetime ES2177787T3 (es) | 1995-06-07 | 1996-05-31 | Uso de hidroxietil-almidon para evitar la formacion de adhesiones post-operatorias y como dispositivo de barrera intra-cavidades. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5807833A (es) |
EP (1) | EP0831856B1 (es) |
JP (2) | JP4184431B2 (es) |
AT (1) | ATE221782T1 (es) |
AU (1) | AU722836B2 (es) |
CA (1) | CA2223573C (es) |
DE (1) | DE69622863T2 (es) |
ES (1) | ES2177787T3 (es) |
WO (1) | WO1996040168A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807833A (en) * | 1995-06-07 | 1998-09-15 | University Of Southern California | Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device |
GB9810127D0 (en) | 1998-05-13 | 1998-07-08 | Ml Lab Plc | Prevention of surgical adhesions |
EP1085920B1 (en) * | 1998-05-13 | 2001-12-19 | ML Laboratories PLC | Dextrin-containing composition for preventing surgical adhesions |
AU2002233952A1 (en) * | 2000-12-05 | 2002-06-18 | Haemonetics Corporation | Method for precipitating red blood cells |
US7332179B2 (en) | 2003-12-12 | 2008-02-19 | Kimberly-Clark Worldwide, Inc. | Tissue products comprising a cleansing composition |
EP1809303B1 (en) * | 2004-09-23 | 2019-03-06 | ARC Medical Devices, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
US7642395B2 (en) | 2004-12-28 | 2010-01-05 | Kimberly-Clark Worldwide, Inc. | Composition and wipe for reducing viscosity of viscoelastic bodily fluids |
US9119901B2 (en) * | 2005-04-28 | 2015-09-01 | Warsaw Orthopedic, Inc. | Surface treatments for promoting selective tissue attachment to medical impants |
US8414907B2 (en) | 2005-04-28 | 2013-04-09 | Warsaw Orthopedic, Inc. | Coatings on medical implants to guide soft tissue healing |
US20090062233A1 (en) | 2007-08-09 | 2009-03-05 | Xin Ji | Modified starch material of biocompatible hemostasis |
CN104888263B (zh) | 2008-01-14 | 2018-11-30 | 北京环球利康科技有限公司 | 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料 |
EP2832360A1 (en) | 2013-07-30 | 2015-02-04 | Fresenius Kabi Deutschland GmbH | Polysaccharide for use in preventing metastasis formation and/or relapse |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE456346B (sv) * | 1984-07-23 | 1988-09-26 | Pharmacia Ab | Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning |
JPS62228021A (ja) * | 1986-02-24 | 1987-10-06 | エチコン・インコ−ポレ−テツド | 手術後の癒着の形成を防止または減少する方法 |
US4913903A (en) * | 1987-02-04 | 1990-04-03 | Alza Corporation | Post-surgical applications for bioerodible polymers |
US5080893A (en) * | 1988-05-31 | 1992-01-14 | University Of Florida | Method for preventing surgical adhesions using a dilute solution of polymer |
SE8900586L (sv) * | 1989-02-21 | 1990-08-22 | Pharmacia Ab | Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader |
US5219895A (en) * | 1991-01-29 | 1993-06-15 | Autogenesis Technologies, Inc. | Collagen-based adhesives and sealants and methods of preparation and use thereof |
JP3174400B2 (ja) * | 1992-05-28 | 2001-06-11 | 味の素ファルマ株式会社 | 腹腔洗浄液 |
DE4242926C2 (de) * | 1992-12-18 | 1994-12-15 | Fresenius Ag | Dialyselösung für die Peritonealdialyse |
US5807833A (en) * | 1995-06-07 | 1998-09-15 | University Of Southern California | Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device |
US5639468A (en) * | 1995-06-07 | 1997-06-17 | University Of Southern California | Method for reducing or preventing post-surgical adhesion formation using manoalide and analogs thereof |
-
1995
- 1995-06-07 US US08/482,235 patent/US5807833A/en not_active Expired - Lifetime
-
1996
- 1996-05-31 WO PCT/US1996/008098 patent/WO1996040168A2/en not_active Application Discontinuation
- 1996-05-31 ES ES96916821T patent/ES2177787T3/es not_active Expired - Lifetime
- 1996-05-31 AT AT96916821T patent/ATE221782T1/de not_active IP Right Cessation
- 1996-05-31 EP EP96916821A patent/EP0831856B1/en not_active Revoked
- 1996-05-31 CA CA2223573A patent/CA2223573C/en not_active Expired - Fee Related
- 1996-05-31 AU AU59569/96A patent/AU722836B2/en not_active Ceased
- 1996-05-31 JP JP50087597A patent/JP4184431B2/ja not_active Expired - Lifetime
- 1996-05-31 DE DE69622863T patent/DE69622863T2/de not_active Expired - Fee Related
-
2007
- 2007-12-28 JP JP2007341444A patent/JP2008264495A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0831856A2 (en) | 1998-04-01 |
JPH11506741A (ja) | 1999-06-15 |
EP0831856B1 (en) | 2002-08-07 |
AU5956996A (en) | 1996-12-30 |
JP2008264495A (ja) | 2008-11-06 |
DE69622863T2 (de) | 2002-12-12 |
DE69622863D1 (de) | 2002-09-12 |
US5807833A (en) | 1998-09-15 |
WO1996040168A2 (en) | 1996-12-19 |
ATE221782T1 (de) | 2002-08-15 |
WO1996040168A3 (en) | 1997-01-23 |
JP4184431B2 (ja) | 2008-11-19 |
CA2223573A1 (en) | 1996-12-19 |
CA2223573C (en) | 2011-09-20 |
AU722836B2 (en) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2177787T3 (es) | Uso de hidroxietil-almidon para evitar la formacion de adhesiones post-operatorias y como dispositivo de barrera intra-cavidades. | |
BRPI0512604A (pt) | terapia de drogas em combinação para reduzir a formação de tecido de cicatrização | |
CA2174072A1 (en) | Hydrogel-forming, self-solvating absorbable polyester block copolymers, and methods for use thereof | |
EP0952171A3 (en) | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof | |
NO20001567L (no) | Bioadhesive sammensetninger og fremgangsmÕter for topisk administrering av aktive midler | |
WO1997005185A3 (en) | Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents | |
CA2235919A1 (en) | Non-polymeric sustained release delivery system | |
SE8900586L (sv) | Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader | |
AU2742401A (en) | Methods and compositions for improved delivery devices | |
BR9808581A (pt) | Estabilização de benzimidazóis sensìveis a ácido com combinações de aminoácido/ciclodextrina | |
EA200500149A1 (ru) | Тканевые протективные цитокины для защиты, восстановления и стимуляции реактивных клеток, тканей и органов | |
BRPI0415649A (pt) | método para tratar, prevenir, modificar ou administrar dor, e, composição farmacêutica | |
EP2281828A3 (en) | Compositions comprising modified erythropoietin | |
BR0012863A (pt) | Composições farmacêuticas de "beta"-carbolina | |
BR9713480A (pt) | Recipiente de plástico flexìvel com três câmaras. | |
AR065073A2 (es) | Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo | |
EP0640647A3 (en) | Ion-crosslinked glycosaminoglycan gels to increase soft tissue and for drug delivery. | |
BR0007360A (pt) | Composição de liberação controlada | |
EP1057484A4 (en) | INHIBITORS OF CELL DEATH | |
BRPI0008228B8 (pt) | composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes | |
ATE509637T1 (de) | Temperaturgesteuerte verabreichungssysteme | |
BR0010983A (pt) | Preparações para a aplicação de agentes antiinflamatórios | |
WO1999013054A3 (en) | Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues | |
BRPI0413474A (pt) | uso de interferon e ribavirina e kit para uso no tratamento de infecções virais | |
EP1152002A4 (en) | PYRROL DERIVATIVES AND CELL DEATH INHIBITORS |